GARFIELD-AF Registry

GARFIELD-AF registry

GARFIELD-AF was the largest prospective registry of patients with newly diagnosed atrial fibrillation
Back to GARFIELD-AF
Keep Up to Date Login
Menu
  • Home

      • The TRI team continues to publish papers based on data accrued during the study (#50 was published in April 2021). Click on a branch of the tree to access the papers associated with that area.

        • Burden of Disease
        • Risk Stratification
        • Treatment Practices
        • Therapy Persistence
        • Clinical Outcomes
        • Geographic Differences
        • Health Economics
  • About
    • About GARFIELD-AF
    • Our Governance
    • About Atrial Fibrillation
    • External Links
  • Risk Calculator
  • Publications & Presentations
  • Newsletters
  • Media
  • Community Page

ESC Congress Symposium Presentations

Symposium Presentations - (Slides via Community access)

A Celebration of the Evidence from the GARFIELD-AF Registry - Prof Ajay Kakkar

Click to view... [read more]

23 Sep 19

Clinical Effectiveness of Routine Care for Stroke Prevention - Prof Keith Fox

Click to view... [read more]

23 Sep 19

Temporal Quality Changes of Stroke Prevention in Atrial Fibrillation - Prof John Camm

Click to view... [read more]

23 Sep 19

Trends in Patient Outcomes with Atrial Fibrillation - Prof Freek Verheugt

Click to view ... [read more]

23 Sep 19

Congress Posters

Evaluation of the effect of oral anticoagulants on all-cause mortality within 3 months of the diagnosis of atrial fibrillation: results from the GARFIELD-AF registry

Click to Download... [read more]

23 Sep 19

Why do clinicians withhold anticoagulation in patients with atrial fibrillation and CHA 2DS2-VASc score ≥2?

Click to Download... [read more]

23 Sep 19

Why do clinicians prescribe oral anticoagulation in patients with atrial fibrillation despite a low CHA2DS2-VASc score?

Click to Download... [read more]

23 Sep 19

The economic burden attributable to atrial fibrillation in nine European countries: perspectives from the GARFIELD-AF registry

Click to Download... [read more]

23 Sep 19
Previous Page

Community members, please login to view additional information

Global status

Read more
Total patients 57,262
Recruitment Recruitment closed
Follow-up
Study end: 2018

Contact Us

To find out more about GARFIELD-AF, please contact the Thrombosis Research Institute

info@tri-london.ac.uk Contact Us

Follow Us

Keep up to date

Sign up to our newsletter to receive news and updates from us

Keep Up to Date

Funding

The GARFIELD-AF registry was funded by an unrestricted research grant from Bayer AG, and the ongoing work is supported by the Thrombosis Research Institute.

© Copyright TRI 2023

All Rights Reserved. No part of this site may be reproduced without our permission.

  • About TRI
  • Cookie Notice
  • Privacy Policy
  • Terms of Use

Members Login

Coming soon… If you would like to be notified of when this is available click here and add your details to receive updates

Newsletter Signup




    Please see our Privacy Policy and Cookie Policy

    Contact Us

      To find out more about GARFIELD-AF, please contact the Thrombosis Research Institute

      E: garfield@tri-london.ac.uk
      T: 0203 198 9947